Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer.

MLA

Tserpeli, Victoria, et al. “Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer.” Cancers, vol. 14, no. 1, Jan. 2022, p. 4. EBSCOhost, https://doi.org/10.3390/cancers14010004.

APA

Tserpeli, V., Stergiopoulou, D., Londra, D., Giannopoulou, L., Buderath, P., Balgkouranidou, I., Xenidis, N., Grech, C., Obermayr, E., Zeillinger, R., Pavlakis, K., Rampias, T., Kakolyris, S., Kasimir-Bauer, S., & Lianidou, E. S. (2022). Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer. Cancers, 14(1), 4. https://doi.org/10.3390/cancers14010004

Chicago

Tserpeli, Victoria, Dimitra Stergiopoulou, Dora Londra, Lydia Giannopoulou, Paul Buderath, Ioanna Balgkouranidou, Nikolaos Xenidis, et al. 2022. “Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer.” Cancers 14 (1): 4. doi:10.3390/cancers14010004.